Candriam S.C.A. Pacira Bio Sciences, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$27.7 - $35.48 $277,000 - $354,799	-10,000 Reduced 5.21%	181,901 $5.32 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $1.05 Million - $1.37 Million	40,000 Added 26.33%	191,901 $6.47 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $1.23 Million - $1.6 Million	-40,000 Reduced 20.84%	151,901 $4.66 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $47.5 $433,439 - $570,000	12,000 Added 6.67%	191,901 $7.69 Million
Q1 2023 May 12, 2023	SELL	$35.53 - $43.38 $1.67 Million - $2.04 Million	-47,010 Reduced 20.72%	179,901 $7.34 Million
Q4 2022 Feb 13, 2023	BUY	$38.19 - $57.45 $1.8 Million - $2.7 Million	47,010 Added 26.13%	226,911 $8.76 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $2.56 Million - $2.94 Million	50,000 Added 38.49%	179,901 $9.57 Million
Q2 2022 Aug 03, 2022	SELL	$51.49 - $81.64 $2.27 Million - $3.61 Million	-44,180 Reduced 25.38%	129,901 $7.57 Million
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $3.36 Million - $4.28 Million	-56,000 Reduced 24.34%	174,081 $13.3 Million
Q4 2021 Feb 10, 2022	BUY	$47.97 - $62.21 $1.21 Million - $1.56 Million	25,121 Added 12.26%	230,081 $13.8 Million
Q3 2021 Nov 09, 2021	BUY	$54.64 - $61.3 $11.2 Million - $12.6 Million	204,960 New	204,960 $11.5 Million
Q3 2018 Nov 07, 2018	SELL	$32.85 - $52.0 $1.46 Million - $2.31 Million	-44,440 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$29.98 - $46.35 $76,748 - $118,656	-2,560 Reduced 5.45%	44,440 $1.38 Million
Q4 2017 Feb 07, 2018	SELL	$31.85 - $46.95 $191,100 - $281,700	-6,000 Reduced 11.32%	47,000 $2.15 Million
Q3 2017 Nov 03, 2017	BUY	$35.7 - $39.5 $1.89 Million - $2.09 Million	53,000	53,000 $1.99 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account